Aqueous humor concentrations of topically administered caspofungin in rabbits

Ophthalmic Research

Volumn 41, Issue 2, 2009, Pages 102-105

  Vorwerk, Christian K ^a   Tuchen, S ^a   Streit, F ^b   Binder, L ^b   Hofmuller W ^a   Behrens Baumann, W ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Animal model, rabbits; Caspofungin, ocular penetration; Caspofungin, topical application; Keratomycosis

Indexed keywords

CASPOFUNGIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM ABRASION; CORNEA INJURY; DRUG PENETRATION; LIQUID CHROMATOGRAPHY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; TANDEM MASS SPECTROMETRY; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIFUNGAL AGENTS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; ECHINOCANDINS; MALE; MICROBIAL SENSITIVITY TESTS; RABBITS; TANDEM MASS SPECTROMETRY;

EID: 58149100910     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000187627     Document Type: Article

References (13)

1. O'Day DM, Head WS: Advances in the management of keratomycosis and Acanthamoeba keratitis. Cornea 2000;19:681-687.
2. Behrens-Baumann W: Mycosis of the Eye and Its Adnexa. Dev Ophthalmol. Basel, Karger, 1999, vol 32.
3. Klotz SA, Penn CC, Negvesky GJ, Butrus SI: Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000;13:662-685.
4. Arathoon EG, Gotuzzo E, Noriega LM, Berman RS, Di Nubile MJ, Sable CA: Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother 2002;46:451-457.
5. Goldblum D, Frueh BE, Sarra GM, Katsoulis K, Zimmerli S: Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother 2005;49:1359-1363.
6. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J: Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002;347:2020-2029.
7. Khan FA, Slain D, Khakoo RA: Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy 2007;27:1711-1721.
8. Goldblum D, Fausch K, Frueh BE, Theurillat R, Thormann W, Zimmerli S: Ocular penetration of caspofungin in a rabbit uveitis model. Graefes Arch Clin Exp Ophthalmol 2007;245:825-833.
9. Villanueva A, Gotuzzo E, Arathoon EG, Noriega LM, Kartsonis NA, Lupinacci RJ, Smietana JM, Di Nubile MJ, Sable CA: A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med 2002;113:294-299.
10. Schreiber W, Olbrisch A, Vorwerk CK, Konig W, Behrens-Baumann W: Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci 2003;44:2634-2643.
11. Behrens-Baumann W: Topical antimycotics in ophthalmology. Ophthalmologica 1997;211(suppl 1):33-38.
12. Imamura Y, Chandra J, Mukherjee PK, Lattif AA, Szczotka-Flynn LB, Pearlman E, Lass JH, O'Donnell K, Ghannoum MA: Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother 2008;52:171-182.
13. Lewis K: Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008;322:107-131.